CMCSA
35
8
PPL
44
-5
SHW
33
-3
STZ
18
-12
WM
56
2
EQIX
57
-2
WMT
70
3
LH
43
-2
GM
44
-3
CAH
48
-2
PYPL
43
-13
HBAN
39
-9
PNC
44
-8
FFIV
62
-4
HP
56
4
ALLE
16
-3
AMAT
44
-4
AMZN
53
-2
MSFT
39
-4
AMG
52
-2
CMCSA
35
8
PPL
44
-5
SHW
33
-3
STZ
18
-12
WM
56
2
EQIX
57
-2
WMT
70
3
LH
43
-2
GM
44
-3
CAH
48
-2
PYPL
43
-13
HBAN
39
-9
PNC
44
-8
FFIV
62
-4
HP
56
4
ALLE
16
-3
AMAT
44
-4
AMZN
53
-2
MSFT
39
-4
AMG
52
-2
Financhill
Back

iShares MSCI New Zealand ETF Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
39

ENZL
iShares MSCI New Zealand ETF

Last Price:
$44.26
Seasonality Move:
2.4%
Sell
42

ITCI
Intra-Cellular Therapies

Last Price:
$94.86
Seasonality Move:
2.9%
Sell
39
iShares MSCI New Zealand ETF (ENZL) is a Sell

Is iShares MSCI New Zealand ETF a Buy, Sell or Hold?

  • The current iShares MSCI New Zealand ETF [ENZL] share price is $44.02. The Score for ENZL is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ENZL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ENZL Stock Price Chart

What is iShares MSCI New Zealand ETF's stock price today?

  • The iShares MSCI New Zealand ETF share price today is $44.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENZL is experiencing selling pressure, which indicates risk of future bearish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $94.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

ENZL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 34.31 Sell
Chaikin Money Flow: -6374 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.85 - 46.83) Sell
Bollinger Bands (100): (46.43 - 49.37) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 71.02 Buy
Chaikin Money Flow: 1717350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.26 - 87.1) Buy
Bollinger Bands (100): (74.04 - 85.96) Buy

ENZL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.27 Sell
20-day SMA: 45.45 Sell
50-day SMA: 46.78 Sell
200-day SMA: 46.74 Sell
8-day EMA: 45.1 Sell
20-day EMA: 45.63 Sell
50-day EMA: 46.54 Sell
200-day EMA: 46.95 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.68 Buy
20-day SMA: 84.71 Buy
50-day SMA: 85.48 Buy
200-day SMA: 75.72 Buy
8-day EMA: 85.91 Buy
20-day EMA: 85.03 Buy
50-day EMA: 83.75 Buy
200-day EMA: 76.64 Buy

iShares MSCI New Zealand ETF Earnings Growth & ENZL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

iShares MSCI New Zealand ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):